13D Filing: OrbiMed Advisors and Rhythm Pharmaceuticals Inc (RYTM)

Page 14 of 14

Page 14 of 14 – SEC Filing

EXHIBIT INDEX
Exhibit
Description
1.
Joint Filing Agreement among OrbiMed Advisors LLC, OrbiMed Capital GP V LLC and Samuel D. Isaly.
2.
Lock-Up Agreement.
3.
Amended and Restated Investors’ Rights Agreement by and among the Issuer and each of the persons listed on Schedule A thereto, dated as of August 21, 2017 (incorporated by reference to Exhibit 4.2 to the Issuer’s Registration Statement on Form S-1 (SEC 333-220337), filed with the SEC on September 5, 2017).


Follow Rhythm Pharmaceuticals Inc. (NASDAQ:RYTM)

Page 14 of 14